Please wait...

Quick Stats

Offers Claimed:


Downloaded Today:


Tri-previfem Prescription
view details
Generic Name: Ethinyl Estradiol and Norgestimate (ETH in il es tra DYE ole & nor JES ti mate)
Brand Name: Estarylla, Femynor, Mili, Mono-Linyah, MonoNessa, ...show all 25 brand names.
Easy-to-read patient leaflet for Tri-Previfem. Includes indications, proper use, special instructions, precautions, and possible side effects. Average Savings for tri-previfem (generic): 26.02%
Generic Name: Ethinyl Estradiol and Norgestimate (ETH in il es tra DYE ole & nor JES ti mate)
Brand Name: Estarylla, Femynor, Mili, Mono-Linyah, MonoNessa, ...show all 25 brand names.
Easy-to-read patient leaflet for Tri-Previfem. Includes indications, proper use, special instructions, precautions, and possible side effects. Average Savings for tri-previfem (generic): 26.02%
  • Select Your Prescription Settings
  • X
30 tablets of Tri-previfem 40 mg
  • Select Your Prescription Settings
  • X

Quick Stats

Offers Claimed: 56

Downloaded Today: 139

Set your location
for drug prices near you

Tri-previfem Coupons & Prices

Set your location
for drug prices near you

Enter your ZIP Code

Please wait while the prices are loaded...
Click here to try again.

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Tri-previfem Drug Information:

This is not a list of all drugs or health problems that interact with Tri-Previfem (ethinyl Estradiol and norgeStimate). Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take Tri-Previfem (ethinyl Estradiol and norgeStimate) with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor. Use Tri-Previfem (ethinyl Estradiol and norgeStimate) as ordered by your doctor. Read all information given to you. Follow all instructions closely. Learn more

Tri-previfem Side Effects

Note: This document contains side effect information about ethinyl estradiol / norgestimate. Some of the dosage forms listed on this page may not apply to the brand name Tri-Previfem.

For the Consumer

Applies to ethinyl estradiol / norgestimate: oral tablet


Oral route (Tablet)

Cigarette smoking increases the risk of serious cardiovascular side effects from combination oral contraceptive use. This risk increases with age and the number of cigarettes smoked and is quite marked in women over 35 years of age. Use of combination oral contraceptives is contraindicated in women over the age of 35 who smoke

Along with its needed effects, ethinyl estradiol / norgestimate may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking ethinyl estradiol / norgestimate:

Incidence not known

  • Absent, missed, or irregular menstrual periods
  • anxiety
  • change in vision
  • changes in skin color
  • chest pain or discomfort
  • chills
  • clay-colored stools
  • constipation
  • cough
  • dark urine
  • diarrhea
  • dizziness or lightheadedness
  • fainting
  • fever
  • headache
  • hives or welts
  • itching skin
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
  • loss of appetite
  • medium to heavy, irregular vaginal bleeding between regular monthly periods, which may require the use of a pad or a tampon
  • nausea
  • pain or discomfort in the arms, jaw, back, or neck
  • pain, tenderness, or swelling of the foot or leg
  • pains in the chest, groin, or legs, especially in the calves of the legs
  • pounding in the ears
  • rash
  • redness of the skin
  • severe headaches of sudden onset
  • slow or fast heartbeat
  • stomach pain
  • sudden loss of coordination or slurred speech
  • sudden troubled breathing
  • sweating
  • unusual tiredness or weakness
  • vomiting
  • vomiting of blood

Some side effects of ethinyl estradiol / norgestimate may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

  • Bloating
  • blotchy spots on the exposed skin
  • breast enlargement or tenderness
  • discouragement
  • feeling sad or empty
  • irritability
  • itching of the vagina or outside the genitals
  • loss of interest or pleasure
  • pain during sexual intercourse
  • stomach cramps
  • thick, white curd-like vaginal discharge without odor or with mild odor
  • tiredness
  • trouble concentrating
  • trouble sleeping
  • trouble wearing contact lenses

For Healthcare Professionals

Applies to ethinyl estradiol / norgestimate: oral tablet


The most frequently reported side effects were headache/migraine, nausea/vomiting, gastrointestinal disorder, diarrhea, abdominal/gastrointestinal pain, vaginal infection, genital discharge, breast issues (including breast pain, discharge, and enlargement), dysmenorrhea, metrorrhagia, abnormal withdrawal bleeding, mood disorders (including depression and mood altered), flatulence, nervousness, rash, and changes in weight (including weight increased or decreased).


Very common (10% or more): Breast issues (10.3%), dysmenorrhea, metrorrhagia, abnormal withdrawal bleeding

Common (1% to 10%): Vaginal infection, genital discharge, breast tenderness, breast pain, breast enlargement, breast swelling, breast discharge, breast discomfort, nipple pain, menstrual discomfort, menstrual disorder, vulvovaginal infection, urinary tract infection, amenorrhea, premenstrual syndrome

Uncommon (0.1% to 1%): Ovarian cyst, vulvovaginal dryness

Rare (less than 0.1%): Vaginal discharge

Frequency not reported: Suppressed lactation

Some women experience oligomenorrhea and amenorrhea following termination or oral contraceptive use.


Very common (10% or more): Nausea/vomiting (16.3%), gastrointestinal disorder, diarrhea

Common (1% to 10%): Abdominal/gastrointestinal pain, flatulence, abdominal distention, constipation

Rare (less than 0.1%): Pancreatitis

Nervous system

Very common (10% or more): Headache/migraine (up to 33.6%)

Common (1% to 10%): Dizziness

Uncommon (0.1% to 1%): Syncope, paresthesia

Frequency not reported: Convulsion, cerebrovascular accident


Uncommon (0.1% to 1%): Palpitation, thrombosis, hypertension, hot flush

Rare (less than 0.1%): Tachycardia, arterial thromboembolism

Frequency not reported: Myocardial infarction, venous thromboembolic event, deep vein thrombosis


Uncommon (0.1% to 1%): Dyspnea

Frequency not reported: Pulmonary embolism


Common (1% to 10%): Rash, acne

Uncommon (0.1% to 1%): Alopecia, hirsutism, urticaria, pruritus, erythema, skin discoloration

Rare (less than 0.1%): Hyperhidrosis, photosensitivity reaction

Frequency not reported: Angioedema, erythema nodosum, night sweats


Common (1% to 10%): Weight fluctuation, fluid retention

Rare (less than 0.1%): Appetite disorder

Frequency not reported: Dyslipidemia


Common (1% to 10%): Muscle spasms, pain in extremity, back pain

Uncommon (0.1% to 1%): Myalgia


Uncommon (0.1% to 1%): Cervical dysplasia

Rare (less than 0.1%): Breast cyst

Frequency not reported: Breast cancer, carcinoma of the cervix in situ, hepatic adenoma, breast cancer, benign breast neoplasm, focal nodular hyperplasia, fibroadenoma of breast


Rare (less than 0.1%): Hepatitis


Common (1% to 10%): Depression, mood altered, mood disorder, nervousness, insomnia

Uncommon (0.1% to 1%): Anxiety, libido disorder

Frequency not reported: Irritability, mood swing


Common (1% to 10%): Hypersensitivity


Common (1% to 10%): Weight increased, weight decreased, fatigue, chest pain, asthenic conditions, edema


Uncommon (0.1% to 1%): Vision impaired, dry eye

Frequency not reported: Contact lens intolerance, retinal vascular thrombosis

Editorial References and Review

Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/3/2022.

Source: Drugs.com Tri-previfem (www.drugs.com/cdi/tri-previfem.html).